Glucose-based spiro-oxathiazoles as in vivo anti-hyperglycemic agents through glycogen phosphorylase inhibition.
Goyard D, Kónya B, Czifrák K, Larini P, Demontrond F, Leroy J, Balzarin S, Tournier M, Tousch D, Petit P, Duret C, Maurel P, Docsa T, Gergely P, Somsák L, Praly JP, Azay-Milhau J, Vidal S.
Goyard D, et al. Among authors: azay milhau j.
Org Biomol Chem. 2020 Feb 7;18(5):931-940. doi: 10.1039/c9ob01190k. Epub 2020 Jan 10.
Org Biomol Chem. 2020.
PMID: 31922157